6. Haematological and biochemical indices within the ranges shown below. These measurements must be performed within one week before their first dose of mAb (BI-1206 and/or rituximab) as part of this study (Day -14 to Day -7 for CLL patients recruited to the combination expansion, Day-7 to Day 1 for all other patients).